Cargando…
Concentrations of perfluoroalkyl and polyfluoroalkyl substances and blood glucose in pregnant women
BACKGROUND: Evidence on the association between exposure to perfluoroalkyl and polyfluoroalkyl substances (PFASs) and blood glucose concentrations in pregnant women is inconsistent. This study aimed to examine the association between PFAS exposure and the concentrations of fasting plasma glucose (FP...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7433207/ https://www.ncbi.nlm.nih.gov/pubmed/32807188 http://dx.doi.org/10.1186/s12940-020-00640-8 |
_version_ | 1783571960244994048 |
---|---|
author | Ren, Yanfeng Jin, Longmei Yang, Fen Liang, Hong Zhang, Zhaofeng Du, Jing Song, Xiuxia Miao, Maohua Yuan, Wei |
author_facet | Ren, Yanfeng Jin, Longmei Yang, Fen Liang, Hong Zhang, Zhaofeng Du, Jing Song, Xiuxia Miao, Maohua Yuan, Wei |
author_sort | Ren, Yanfeng |
collection | PubMed |
description | BACKGROUND: Evidence on the association between exposure to perfluoroalkyl and polyfluoroalkyl substances (PFASs) and blood glucose concentrations in pregnant women is inconsistent. This study aimed to examine the association between PFAS exposure and the concentrations of fasting plasma glucose (FPG) and one-hour plasma glucose (1 h-PG) after a 50-g oral glucose tolerance test in pregnant women. METHODS: The study was based on the Shanghai-Minhang Birth Cohort, in which 1292 pregnant women were recruited. Among them, 981 women provided blood samples (at 12–16 gestational weeks) for PFAS measurement. FPG data collected from 856 women at 12–20 GW and 1 h-PG data collected from 705 women at 20–28 GW were obtained through medical records from the routine prenatal care system. High FPG or 1 h-PG was defined as ≥90th percentile of FPG or 1 h-PG. The analysis of eight PFASs was conducted in this study: perfluorohexane sulfonate (PFHxS), perfluorooctane sulfonate (PFOS), perfluorooctanoic acid (PFOA), perfluorononanoic acid (PFNA), perfluorodecanoic acid (PFDA), perfluoroundecanoic acid (PFUdA), perfluorododecanoic acid (PFDoA), and perfluorotridecanoic acid (PFTrDA). The odds ratios (ORs) and associated 95% confidence intervals (CIs) were estimated to determine the associations of each PFAS compound with high FPG and 1 h-PG from a logistic regression model. RESULTS: After adjustment for potential confounders, most PFASs were positively associated with high 1 h-PG concentrations. The OR for high 1 h-PG concentrations was 1.87 (95% CI: 1.15–3.05) with a one log unit increase of PFOS; similar associations were observed for PFNA (OR: 2.15, 95% CI: 1.24–3.74), PFDA (OR: 1.61, 95% CI: 1.10–2.44), PFUdA (OR: 1.71, 95% CI: 1.12–2.62), and PFDoA (OR: 1.34, 95% CI: 1.00–1.81). When the PFAS concentrations were categorized into three groups by tertiles, the highest tertiles of PFOS, PFOA, PFNA, PFDA, PFDoA, and PFTrDA had a statistically significant increase in the risk of high 1 h-PG concentrations compared with the lowest tertiles. No statistically significant association was observed between PFAS exposure and high FPG. CONCLUSION: PFAS exposure was associated with an increased risk of high 1 h-PG among pregnant women, but no such association was observed for FPG. |
format | Online Article Text |
id | pubmed-7433207 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-74332072020-08-19 Concentrations of perfluoroalkyl and polyfluoroalkyl substances and blood glucose in pregnant women Ren, Yanfeng Jin, Longmei Yang, Fen Liang, Hong Zhang, Zhaofeng Du, Jing Song, Xiuxia Miao, Maohua Yuan, Wei Environ Health Research BACKGROUND: Evidence on the association between exposure to perfluoroalkyl and polyfluoroalkyl substances (PFASs) and blood glucose concentrations in pregnant women is inconsistent. This study aimed to examine the association between PFAS exposure and the concentrations of fasting plasma glucose (FPG) and one-hour plasma glucose (1 h-PG) after a 50-g oral glucose tolerance test in pregnant women. METHODS: The study was based on the Shanghai-Minhang Birth Cohort, in which 1292 pregnant women were recruited. Among them, 981 women provided blood samples (at 12–16 gestational weeks) for PFAS measurement. FPG data collected from 856 women at 12–20 GW and 1 h-PG data collected from 705 women at 20–28 GW were obtained through medical records from the routine prenatal care system. High FPG or 1 h-PG was defined as ≥90th percentile of FPG or 1 h-PG. The analysis of eight PFASs was conducted in this study: perfluorohexane sulfonate (PFHxS), perfluorooctane sulfonate (PFOS), perfluorooctanoic acid (PFOA), perfluorononanoic acid (PFNA), perfluorodecanoic acid (PFDA), perfluoroundecanoic acid (PFUdA), perfluorododecanoic acid (PFDoA), and perfluorotridecanoic acid (PFTrDA). The odds ratios (ORs) and associated 95% confidence intervals (CIs) were estimated to determine the associations of each PFAS compound with high FPG and 1 h-PG from a logistic regression model. RESULTS: After adjustment for potential confounders, most PFASs were positively associated with high 1 h-PG concentrations. The OR for high 1 h-PG concentrations was 1.87 (95% CI: 1.15–3.05) with a one log unit increase of PFOS; similar associations were observed for PFNA (OR: 2.15, 95% CI: 1.24–3.74), PFDA (OR: 1.61, 95% CI: 1.10–2.44), PFUdA (OR: 1.71, 95% CI: 1.12–2.62), and PFDoA (OR: 1.34, 95% CI: 1.00–1.81). When the PFAS concentrations were categorized into three groups by tertiles, the highest tertiles of PFOS, PFOA, PFNA, PFDA, PFDoA, and PFTrDA had a statistically significant increase in the risk of high 1 h-PG concentrations compared with the lowest tertiles. No statistically significant association was observed between PFAS exposure and high FPG. CONCLUSION: PFAS exposure was associated with an increased risk of high 1 h-PG among pregnant women, but no such association was observed for FPG. BioMed Central 2020-08-17 /pmc/articles/PMC7433207/ /pubmed/32807188 http://dx.doi.org/10.1186/s12940-020-00640-8 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Ren, Yanfeng Jin, Longmei Yang, Fen Liang, Hong Zhang, Zhaofeng Du, Jing Song, Xiuxia Miao, Maohua Yuan, Wei Concentrations of perfluoroalkyl and polyfluoroalkyl substances and blood glucose in pregnant women |
title | Concentrations of perfluoroalkyl and polyfluoroalkyl substances and blood glucose in pregnant women |
title_full | Concentrations of perfluoroalkyl and polyfluoroalkyl substances and blood glucose in pregnant women |
title_fullStr | Concentrations of perfluoroalkyl and polyfluoroalkyl substances and blood glucose in pregnant women |
title_full_unstemmed | Concentrations of perfluoroalkyl and polyfluoroalkyl substances and blood glucose in pregnant women |
title_short | Concentrations of perfluoroalkyl and polyfluoroalkyl substances and blood glucose in pregnant women |
title_sort | concentrations of perfluoroalkyl and polyfluoroalkyl substances and blood glucose in pregnant women |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7433207/ https://www.ncbi.nlm.nih.gov/pubmed/32807188 http://dx.doi.org/10.1186/s12940-020-00640-8 |
work_keys_str_mv | AT renyanfeng concentrationsofperfluoroalkylandpolyfluoroalkylsubstancesandbloodglucoseinpregnantwomen AT jinlongmei concentrationsofperfluoroalkylandpolyfluoroalkylsubstancesandbloodglucoseinpregnantwomen AT yangfen concentrationsofperfluoroalkylandpolyfluoroalkylsubstancesandbloodglucoseinpregnantwomen AT lianghong concentrationsofperfluoroalkylandpolyfluoroalkylsubstancesandbloodglucoseinpregnantwomen AT zhangzhaofeng concentrationsofperfluoroalkylandpolyfluoroalkylsubstancesandbloodglucoseinpregnantwomen AT dujing concentrationsofperfluoroalkylandpolyfluoroalkylsubstancesandbloodglucoseinpregnantwomen AT songxiuxia concentrationsofperfluoroalkylandpolyfluoroalkylsubstancesandbloodglucoseinpregnantwomen AT miaomaohua concentrationsofperfluoroalkylandpolyfluoroalkylsubstancesandbloodglucoseinpregnantwomen AT yuanwei concentrationsofperfluoroalkylandpolyfluoroalkylsubstancesandbloodglucoseinpregnantwomen |